Charles River Laboratories reported $172.36M in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Anthem ANTM:US $ 2558M 58M
Catalent CTLT:US $ 251M 37M
Cigna CI:US $ 2547M 83M
Danaher DHR:US $ 2549M 12.71M
Illumina ILMN:US $ 121M 69M
Intrexon XON:US $ -26.15M 6.84M
Novartis NOVN:VX SF 4129M 217M
Quest Diagnostics DGX:US $ 370M 123M
United Therapeutics UTHR:US $ 150.6M 158.1M
UnitedHealth UNH:US $ 6957M 159M